WHAT WE OFFER
ENHANCING PATIENTS’ LIVES THROUGH INNOVATIVE AND EVIDENCE-BASED MEDICAL POSSIBILITIES VIA OUR THREE(3) BUSINESS UNITS.
Driven by our mission to enhance lives through pharmaceuticals and medical products, we continuously strive to explore and provide clinically proven medical possibilities to address unmet medical needs.
We keep abreast of the latest developments in the medical fields through our Disease Management Ecosystem, reinforcing our collaboration with key opinion leaders, various governmental, private and medical professional bodies through Amet Acies.
OUR STRATEGIC BUSINESS UNITS
We constantly source for advance medical possibilities to improve patients’ lives through our three strategic business units.
PATIENT’S HEALTH AND SAFETY IS OF UTMOST IMPORTANCE
OFFERING EVIDENCE-BASED PRODUCTS, APPROVED BY VARIOUS HEALTH AUTHORITIES.
Our products are sourced from R&D based reputable European healthcare companies with a long history of providing evidence-based, innovative pharmaceuticals and medical products benefiting patients worldwide.
Our Regulatory Affairs and Quality Assurance Department are responsible for protecting and ensuring the quality of our products.
In our unwavering commitment to improve the lives of our patients we will not compromise on health and safety.
Ministry of Health Malaysia
- National Pharmaceutical Regulatory Agency (NPRA)
- Medical Device Authority (MDA)
Ministry of Health Singapore
- Health Sciences Authority (HSA)
Ministry of Health Indonesia
- National Agency of Drug and Food Control (BPOM)
DEDICATED & SPECIALISED COMMERCIAL TEAM
TO SERVE OUR PARTNERS AND CUSTOMERS BETTER.
Our commercial teams are organised based on therapeutic class and skills specialisation.
This ensures efficiency and effectiveness in our execution and are able to provide knowledge related to our customers’ field of practice or interest.
CONSTANT SOURCING OF PIPELINE PRODUCTS TO FUEL OUR GROWTH
To serve our customers (healthcare professionals) better and leverage on our dedicated and specialised Commercial Team.
Our Business Development and Sourcing Department constantly source the world for innovative and clinically proven products, complementing our existing products that focus on disease management.
This also supports our ambition to become “The leading healthcare group in Southeast Asia”, as we gain market share through the continuous launch of new complementary products.
Our guiding principle when sourcing for new products is focused on how each new product will bridge the treatment gaps and make a difference in improving lives.
We focus on the management of a few diseases with our pharmaceutical and medical products, related to the following therapeutic areas.